You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

Arjo_Nurse_Patient_Banner_2135x600.jpg

With people in mind

Arjocare 1x1.jpg

Arjo Australia acquires Lockyer Bio Med Solutions

We would like to announce Arjo Australia has acquired Lockyer Bio Med Solutions. Arjo is a global supplier of medical devices, services and solutions that improve quality of life for people with reduced mobility and age-related health challenges. We create value by improving clinical outcomes for patients and enabling a better work environment for healthcare professionals.

Download Arjo Australia acquires Lockyer Bio Med Solutions (LBMS) announcement

BruinBiometricsSEMscanner_1x1.jpg

Arjo Australia sign a JMA with BBI (Europe) Ltd.

Arjo, a market-leading supplier of medical devices and solutions, today signed a Joint Marketing Agreement with BBI (Europe) Ltd allowing both companies to work together for the promotion of a Pressure Injury (PI) Prevention Solution Set.

Learn more about Arjo Pressure Injury Prevention Solution Set

We care for our customers

We believe in ensuring the comfort and dignity of patients and residents and a secure working environment for caregivers. We believe that putting people first is key to providing the highest standards of care.

Learn more

Nurse helping elderly patient with physiotherapy | arjo.com

Our customers

Through the years, we have worked closely with healthcare professionals to improve the lives of those affected by reduced mobility and age-related conditions. It’s what has given us a unique understanding of the challenges they face and enables us to deliver the right solutions for their specific needs. Time and time again.

Read more about our customers

Investor relations

We will intensify our focus, which will strengthen opportunities for realising our strategy and being able to continue to efficiently develop products and solutions and thus create both positive customer value and shareholder value.

Read more about our investors